The National Research Development Corporation (NRDC), under the Ministry of Science & Technology, and Dabur India have entered into licence agreements for commercialisation of Ayush-64, an ayurvedic formulation for treatment of Malaria, and Ayush-82, an ayurvedic formulation for management of diabetes. Both the formulations have been developed by Central Council for Research in Ayurvedic Sciences, an autonomous body, and the Ministry of AYUSH, an official release said.
The licence agreements were signed by H Purushotham on behalf of NRDCJ and LN Sastry, Head, Healthcare Research, on behalf of Dabur India, it added.